← Leaderboards
Barry Matthew Markaverich
Baylor College Of Medicine
$5,206,019
Attributed
$5,206,019
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $337.2K · FY2005–13$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$5,206,019 · 11
By mechanism
R01$5,129,059 · 3
P41$76,960 · 8
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Tamer M A Mohamed$5,113,243
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationEstradiolResponseMcf7 CellEstrogen ReceptorsLigandsBinding SitesLaboratory RatGene ExpressionFemaleSex BehaviorMaleGenetic TranscriptionBreast NeoplasmsCancer CellAthymic MouseIn VitroSiteTissuesPathway InteractionsAcetylationNucleosomesPeriodicityCell Cycle
Grant awards (27)
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer$290,421
R01 · FY2013 · CA · contact PI
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer$308,958
R01 · FY2012 · CA · contact PI
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer$308,958
R01 · FY2011 · CA · contact PI
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer$318,513
R01 · FY2010 · CA · contact PI
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer$318,513
R01 · FY2009 · CA · contact PI
THF-DIOL STIMULATION OF PLA2, LOX AND COX GENE EXPRESSION$14,542
P41 · FY2009 · RR · contact PI
TETRAHYDROFURAN-DIOLS AND ENDOCRINE DISRUPTION IN ADULT RATS$4,186
P41 · FY2009 · RR · contact PI
THF-DIOL STIMULATION OF PLA2, LOX AND COX GENE EXPRESSION$24,081
P41 · FY2008 · RR · contact PI
TETRAHYDROFURAN-DIOLS AND ENDOCRINE DISRUPTION IN ADULT RATS$4,387
P41 · FY2008 · RR · contact PI
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER$305,024
R01 · FY2007 · ES · contact PI
LEUKOTOXIN DIOLS FROM GROUND CORNCOB BEDDING DISRUPT ESTROUS CYCLICITY$4,632
P41 · FY2007 · RR · contact PI
TETRAHYDROFURAN-DIOLS AND ENDOCRINE DISRUPTION IN ADULT RATS$4,632
P41 · FY2007 · RR · contact PI
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER$314,134
R01 · FY2006 · ES · contact PI
LEUKOTOXIN DIOL FROM CORN COB ANIMAL BEDDING STIMULATES BREAST CANCER CELLS$5,897
P41 · FY2006 · RR · contact PI
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER$242,594
R01 · FY2005 · ES
NOVEL ENDOCRINE DISRUPTING AGENT IN CORN THAT STIMULATES BREAST CANCER CELLS$6,475
P41 · FY2005 · RR
Cell Growth Inhibiton and Estrogen Action$343,318
R01 · FY2004 · CA
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER$328,035
R01 · FY2004 · ES
NOVEL ENDOCRINE DISRUPTING AGENT IN CORN THAT STIMULATES BREAST CANCER CELLS$8,128
P41 · FY2004 · RR
Cell Growth Inhibiton and Estrogen Action$346,150
R01 · FY2003 · CA
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER$332,667
R01 · FY2003 · ES
Cell Growth Inhibiton and Estrogen Action$318,648
R01 · FY2002 · CA
CELL GROWTH INHIBITION AND ESTROGEN ACTION$45,752
R01 · FY2002 · CA
CELL GROWTH INHIBITION AND ESTROGEN ACTION$284,155
R01 · FY2001 · CA
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER$226,977
R01 · FY2001 · ES
CELL GROWTH INHIBITION AND ESTROGEN ACTION$275,878
R01 · FY2000 · CA
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER$220,364
R01 · FY2000 · ES